摘要
心血管疾病已严重危害人类健康,血小板抑制剂可有效改善和预防心血管疾病。噻吩吡啶类药物具有较好的抗血小板凝集的效果,并降低副作用,因此噻吩吡啶类药物抑制剂的研究已成为心血管疾病治疗的热点。本文分析了专利中噻吩吡啶类抗血栓药物的结构改进方向,希望为国内的制药行业在研发方向以及立项过程提供帮助。
At present, cardiovascular disease has seriously jeopardized the health of mankind, and platelet inhibitor can effectively improve and prevent this disease. An antiplatelet agent of thienopyridine have effective and rapid inhibitory effects on platelet aggregation with less side effect, therefore, the study of an antiplatelet agent of thienopyridine has become the focus of the treatment of cardiovascular disease. In this article, we review and analyze the structure modification of thienopyridine in the patents, for the sake of offering a little help to the domestic pharmaceutical industry on patent application or project establishment.
出处
《食品与药品》
CAS
2013年第3期180-183,共4页
Food and Drug
